Literature DB >> 35239141

Protective effect of curcumin against rotenone-induced substantia nigra pars compacta neuronal dysfunction.

L V Darbinyan1, K V Simonyan2, L E Hambardzumyan1, L P Manukyan1, S H Badalyan1, V H Sarkisian1.   

Abstract

Rotenone is involved in the degeneration of dopaminergic neurons, and curcumin may prevent or effectively slow the progression of Parkinson's disease (PD). Previous research has shown that the naturally occurring phenolic compound curcumin can reduce inflammation and oxidation, making it a potential therapeutic agent for neurodegenerative diseases. The present study involves investigation of rotenone-induced histological changes in the brain area, hippocampus using Nissl staining after 35 day of subcutaneous injection of rotenone in adult male rats. We sought to determine whether curcumin could protect against rotenone-induced dopaminergic neurotoxicity in a rat model by in vivo electrical recording from Substantia nigra pars compacta (SNc). Curcumin treatment significantly improved electrical activity of neurons in the SNc of rotenone-induced PD model rats. The pattern of histological alterations corresponds with electrophysiological manifestations.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Curcumin; In vivo electrophysiology; Rotenone; Substantia nigra pars compacta

Mesh:

Substances:

Year:  2022        PMID: 35239141     DOI: 10.1007/s11011-022-00941-6

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  43 in total

1.  Rotenone impairs hippocampal neuronal activity in a rat model of Parkinson's disease.

Authors:  L V Darbinyan; L E Hambardzumyan; K V Simonyan; V A Chavushyan; L P Manukyan; V H Sarkisian
Journal:  Pathophysiology       Date:  2017-01-22

2.  Midbrain dopamine neurons encode a quantitative reward prediction error signal.

Authors:  Hannah M Bayer; Paul W Glimcher
Journal:  Neuron       Date:  2005-07-07       Impact factor: 17.173

3.  'Rejuvenation' protects neurons in mouse models of Parkinson's disease.

Authors:  C Savio Chan; Jaime N Guzman; Ema Ilijic; Jeff N Mercer; Caroline Rick; Tatiana Tkatch; Gloria E Meredith; D James Surmeier
Journal:  Nature       Date:  2007-06-10       Impact factor: 49.962

4.  Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat.

Authors:  S Breit; R Bouali-Benazzouz; R C Popa; T Gasser; A L Benabid; A Benazzouz
Journal:  Exp Neurol       Date:  2006-12-29       Impact factor: 5.330

5.  Protective effects of curcumin against rotenone-induced rat model of Parkinson's disease: in vivo electrophysiological and behavioral study.

Authors:  L V Darbinyan; L E Hambardzumyan; K V Simonyan; V A Chavushyan; L P Manukyan; S A Badalyan; N Khalaji; V H Sarkisian
Journal:  Metab Brain Dis       Date:  2017-07-10       Impact factor: 3.584

Review 6.  Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases.

Authors:  Bharat B Aggarwal; Kuzhuvelil B Harikumar
Journal:  Int J Biochem Cell Biol       Date:  2008-07-09       Impact factor: 5.085

7.  Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease.

Authors:  Pierluigi Caboni; Todd B Sherer; Nanjing Zhang; Georgia Taylor; Hye Me Na; J Timothy Greenamyre; John E Casida
Journal:  Chem Res Toxicol       Date:  2004-11       Impact factor: 3.739

8.  Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine.

Authors:  P Calabresi; P Gubellini; B Picconi; D Centonze; A Pisani; P Bonsi; P Greengard; R A Hipskind; E Borrelli; G Bernardi
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

9.  Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway.

Authors:  Qunli Cui; Xin Li; Hongcan Zhu
Journal:  Mol Med Rep       Date:  2015-12-08       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.